LEADER 03139nam 2200613 450 001 9910788958603321 005 20230725052516.0 010 $a1-4511-7877-8 010 $a1-4511-2502-X 010 $a1-4511-2016-8 010 $a1-4698-7939-5 035 $a(CKB)3400000000000423 035 $a(CaPaEBR)ebrary10824419 035 $a(SSID)ssj0000446084 035 $a(PQKBManifestationID)11299731 035 $a(PQKBTitleCode)TC0000446084 035 $a(PQKBWorkID)10490877 035 $a(PQKB)11683616 035 $a(MiAaPQ)EBC2031997 035 $a(Au-PeEL)EBL2031997 035 $a(CaPaEBR)ebr10824419 035 $a(OCoLC)908511253 035 $a(EXLCZ)993400000000000423 100 $a20100702h20112011 uy| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt 182 $cc 183 $acr 200 10$aPrinciples and practice of psychopharmacotherapy /$fPhilip G. Janicak, Stephen R. Marder, Mani N. Pavuluri 205 $aFifth edition. 210 1$aPhiladelphia :$cWolters Kluwer Health/Lippincott Williams & Wilkins,$d[2011] 210 4$dİ2011 215 $a1 online resource (708 p.) 300 $aRev. edition of: Principles and practice of psychopharmacotherapy / Philip G. Janicak [and others]. 4th edition c2006. 311 $a1-60547-565-3 320 $aIncludes bibliographical references and index. 327 $a(Publisher-supplied data) General Principles -- Pharmacodynamics and Pharmacokinetics -- Assessment of Drug Efficacy and Relevant Clinical Issues -- Indications for Antipsychotics -- Treatment with Antipsychotics -- Indications for Antidepressants --Treatment with Antidepressants -- Therapeutic Neuromodulation -- Indications for Mood Stabilizers -- Treatment with Mood Stabilizers -- Indications for Antianxiety and Sedative-Hypnotic Agents -- Treatment with Antianxiety and Sedative-Hypnotic Agents -- Assessment and Treatment of Anxiety-Related Disorders -- Psychopharmacotherapy in Early Life -- Psychopharmacotherapy in Later Life -- Psychopharmacotherapy in Special Populations. 330 $a"Fully updated for its Fifth Edition, Principles and Practice of Psychopharmacotherapy summarizes the latest data on hundreds of drug and device-based therapies and offers practical, evidence-based guidelines and treatment strategies for virtually every psychiatric disorder. Highlights of this edition include expanded coverage of pharmacogenomics, updates on treatments for elderly patients, and discussion of mechanisms of action for drugs used in sleep disorders, especially narcolepsy"--Provided by publisher. 606 $aMental illness$xChemotherapy 606 $aPsychopharmacology 615 0$aMental illness$xChemotherapy. 615 0$aPsychopharmacology. 676 $a616.89/18 700 $aJanicak$b Philip G$01463835 701 $aMarder$b Stephen R.$f1945-$01463836 701 $aPavuluri$b Mani N$01463837 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910788958603321 996 $aPrinciples and practice of psychopharmacotherapy$93673301 997 $aUNINA